Key takeaways
- • Severity: No clinically significant interaction known.
- • Saxenda (weight management (FDA-approved obesity)) and Dapagliflozin (Farxiga) (SGLT2 inhibitor (diabetes/CV)).
- • Clinical management: Routine combination; no dose adjustment specifically required. Prescribers may advise temporary SGLT2 hold during acute GI illness.
- • Monitoring: Renal function, hydration, glucose; euglycemic DKA vigilance.
Mechanism
No documented pharmacokinetic interaction. Complementary mechanisms with additive A1c reduction and shared cardio-renal benefits. Dehydration risk from SGLT2 can be amplified if GLP-1-related vomiting occurs.
Clinical management
Routine combination; no dose adjustment specifically required. Prescribers may advise temporary SGLT2 hold during acute GI illness.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Saxenda or Dapagliflozin (Farxiga).
Monitoring
Renal function, hydration, glucose; euglycemic DKA vigilance.
When to call your doctor
- fruity breath
- rapid breathing
- abdominal pain with nausea (possible euglycemic DKA)
- dizziness on standing
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Not specifically listed in current FDA label
Editorial confidence: 9/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Dapagliflozin (Farxiga) with Saxenda?
Dapagliflozin (Farxiga) and Saxenda have no clinically significant interaction documented. Standard prescribing applies. Always confirm with your prescriber, since individual medical history can change the calculation.
What's the mechanism of any Saxenda + Dapagliflozin (Farxiga) interaction?
No documented pharmacokinetic interaction. Complementary mechanisms with additive A1c reduction and shared cardio-renal benefits. Dehydration risk from SGLT2 can be amplified if GLP-1-related vomiting occurs.
What should I monitor when on Saxenda + Dapagliflozin (Farxiga)?
Renal function, hydration, glucose; euglycemic DKA vigilance.
When should I call my doctor?
Contact your prescriber if you notice any of: fruity breath; rapid breathing; abdominal pain with nausea (possible euglycemic DKA); dizziness on standing.
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.